Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.23
-0.44 (-1.71%)
At close: Oct 6, 2026, 4:00 PM EDT
25.21
-0.02 (-0.08%)
Pre-market: Oct 7, 2026, 5:31 AM EDT
Beam Therapeutics Revenue
Beam Therapeutics had revenue of $490.00K in the quarter ending June 30, 2026, a decrease of -94.21%. This brings the company's revenue in the last twelve months to $156.04M, up 158.88% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth.
Revenue (ttm)
$156.04M
Revenue Growth
+158.88%
P/S Ratio
16.16
Revenue / Employee
$288,954
Employees
540
Market Cap
2.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 139.74M | 76.23M | 120.01% |
| Dec 31, 2024 | 63.52M | -314.19M | -83.18% |
| Dec 31, 2023 | 377.71M | 316.79M | 520.01% |
| Dec 31, 2022 | 60.92M | 9.08M | 17.51% |
| Dec 31, 2021 | 51.84M | 51.82M | 215,916.67% |
| Dec 31, 2020 | 24.00K | 6.00K | 33.33% |
| Dec 31, 2019 | 18.00K | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harmony Biosciences Holdings | 959.90M |
| ADMA Biologics | 512.28M |
| Zai Lab | 449.61M |
| Precigen | 85.72M |
| Recursion Pharmaceuticals | 54.86M |
| Nurix Therapeutics | 36.77M |
| NewAmsterdam Pharma Company | 7.12M |
| Celldex Therapeutics | 158.00K |
BEAM News
- 15 days ago - Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics today - TheFly
- 15 days ago - Cathie Wood’s ARK Investment buys 103K shares of Beam Therapeutics today - TheFly
- 20 days ago - BEAM Investors Have Opportunity to Join Beam Therapeutics Inc. Fraud Investigation with SBS Law - Business Wire
- 26 days ago - Beam Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 27 days ago - Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today - TheFly
- 27 days ago - Beam Therapeutics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 4 weeks ago - Beam Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 4 weeks ago - Beam Therapeutics falls -12.4% - TheFly